Valuation: Avantor, Inc.

Market Cap 9.73B 8.55B 7.98B 7.32B 13.7B 932B 14.04B 94.6B 36.99B 461B 36.52B 35.72B 1,594B P/E 2026 *
39.4x
P/E 2027 * 33.2x
Enterprise Value 12.75B 11.21B 10.46B 9.6B 17.97B 1,221B 18.41B 124B 48.5B 604B 47.88B 46.84B 2,089B EV / Sales 2026 *
1.96x
EV / Sales 2027 * 1.82x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-17
Director of Finance/CFO 50 2026-06-23
Chief Operating Officer - 2025-11-09
Director TitleAgeSince
Director/Board Member 60 2020-04-21
Chairman 69 2025-12-31
Director/Board Member 62 2021-09-30
Date Insider Type Main position Quantity % Market Cap.
7/24/26 Tax

Compliance Officer

-1,201 0.0002%
6/21/26 Tax

Executive/Senior Manager

-3,010 0.0004%
5/8/26 Buy

Director

10,000 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+15.78%+31.32% - - 8.48B
+0.68%+7.39%-15.63%-4.20% 187B
+0.76%+6.90%-5.30%-0.80% 111B
-0.30%+6.00%+9.95%+70.78% 62.18B
+0.29%-6.62%+21.84%+49.32% 48.4B
+1.24%+9.95%-7.67%-39.93% 45.83B
-1.06%+7.80% - - 34.26B
+0.39%+5.19%-15.90%-43.24% 28.88B
+0.20%-5.85%+33.42%-7.66% 23.72B
+1.95%+11.52%+2.83%+2.08% 22.45B
Average +0.41%+7.24%+2.94%+3.30% 57.22B
Weighted average by Cap. +0.50%+5.79%-3.38%+5.10%

Financials

2026 *2027 *
Net sales 6.51B 5.72B 5.34B 4.9B 9.18B 624B 9.4B 63.33B 24.77B 309B 24.45B 23.92B 1,067B 6.65B 5.85B 5.46B 5.01B 9.37B 637B 9.6B 64.7B 25.3B 315B 24.97B 24.43B 1,090B
Net income 240M 211M 197M 181M 339M 23.02B 347M 2.34B 914M 11.39B 902M 883M 39.38B 290M 255M 238M 218M 409M 27.77B 419M 2.82B 1.1B 13.74B 1.09B 1.06B 47.5B
Net Debt 3.03B 2.66B 2.48B 2.28B 4.26B 290B 4.37B 29.43B 11.51B 143B 11.36B 11.11B 496B 2.37B 2.08B 1.95B 1.79B 3.34B 227B 3.43B 23.08B 9.03B 112B 8.91B 8.72B 389B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
26-07-29 US$14.38 +15.78% 42,795,041
26-07-28 US$12.42 +5.61% 20,344,046
26-07-27 US$11.76 +2.80% 16,504,929
26-07-24 US$11.44 +0.79% 12,278,629
26-07-23 US$11.35 +3.65% 15,496,603
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
14.38USD
Average target price
10.88USD
Spread / Average Target
-24.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock